Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets - Value in Health Regional Issues
The Economic Burden of Asthma in Greece: A Cross-Sectional Study | SpringerLink
Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets - Value in Health Regional Issues
Roles and mechanisms of renalase in cardiovascular disease: A promising therapeutic target - ScienceDirect
Athens struggles to rein in medical excess | Financial Times
2nd Symposium | miectis.org
300+ "���nikos" profiles | LinkedIn
Novartis Case: The "Biggest Scandal in Modern Greece" or a Political Conspiracy?
Nikos MANIADAKIS | Department Chair | BSc, MSc,PhD | National School of Public Health (EDSY), Athens | edsy | Health Services Management
Procurement: The Unexpected Driver of Value-Based Health Care
An Overview of the Healthcare System in Greece - HealthManagement.org
Zekai Sen (born October 25, 1947), Turkish scientist | World Biographical Encyclopedia
300+ "���nikos" profiles | LinkedIn
Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe - Lung Cancer
Andreas Papandreou - Trenfo
Dr. Jeffrey R. Curtis, MD | Birmingham, AL | Rheumatologist | US News Doctors
PDF) PCV87. Comprehensive Overview: Efficacy, Tolerability and Cost- Effectiveness of Irbesartan
20th Roundtable with the Government of Greece | The Economist Events
300+ "���nikos" profiles | LinkedIn
PDF) Comprehensive Overview: Efficacy, Tolerability and Cost- Effectiveness of Irbesartan | Nikos Maniadakis - Academia.edu
British tourist's privates set on fire in Greek club | UK | News | Express.co.uk
Ioannis Metaxas - Wikipedia
Economic evaluation of hemodialysis: Implications for technology assessment in Greece | International Journal of Technology Assessment in Health Care | Cambridge Core
Novartis' internal probe, expert panel find no suspicious payments to Greek officials | Fierce Pharma
